(S)-2-(4-(benzo[b]thiophen-3-yl)-6-methyl-2-oxopyridin-1(2H)-yl)-3-cyclohexyl-N-(thiazol-2-yl)propanamide | 1036207-04-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: (S)-2-(4-(benzo[b]thiophen-3-yl)-6-methyl-2-oxopyridin-1(2H)-yl)-3-cyclohexyl-N-(thiazol-2-yl)propanamide
• 英文别名: (2S)-2-[4-(1-benzothiophen-3-yl)-2-methyl-6-oxopyridin-1-yl]-3-cyclohexyl-N-(1,3-thiazol-2-yl)propanamide
• CAS: 1036207-04-1
• 化学式: C₂₆H₂₇N₃O₂S₂
• 分子量: 477.651
• InChiKey: TZPNUFOHESZPFS-QFIPXVFZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.4
• 重原子数：
  33
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  119
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• GLUCOKINASE ACTIVATORS
  申请人：Cheruvallath Zacharia

  公开号：US20090105255A1

  公开（公告）日：2009-04-23

  Compounds of the following formula are provided for use with glucokinase: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
• Glucokinase Activators
  申请人：Cheruvallath Zacharia

  公开号：US20120252814A1

  公开（公告）日：2012-10-04

  Compounds of the following formula are provided for use with glucokinase: wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
• US8163779B2
  申请人：——

  公开号：US8163779B2

  公开（公告）日：2012-04-24
• US8530499B2
  申请人：——

  公开号：US8530499B2

  公开（公告）日：2013-09-10
• [EN] GLUCOKINASE ACTIVATORS<br/>[FR] ACTIVATEURS DE GLUCOKINASE
  申请人：TAKEDA SAN DIEGO INC

  公开号：WO2008079787A2

  公开（公告）日：2008-07-03

  (EN) Compounds of the following formula are provided for use with glucokinase: Formula (I), wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.(FR) L'invention concerne des composés représentés par la formule suivante destinés à une utilisation avec une glucokinase. Les variables sont telles que définies dans les spécifications. L'invention concerne aussi des compositions pharmaceutiques, des kits et des articles de manufacture comprenant ces composés, des procédés et des intermédiaires qui conviennent pour la fabrication de ces composés et des procédés d'utilisation de ces composés.